Internationally known AIDS and HIV researcher Angela Kashuba, PharmD, has been appointed chair of the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy. Kashuba succeeds Kim Brouwer, PharmD, PhD, who has been named associate dean of research and graduate education at the School.
Kashuba, is the School’s John A. and Deborah S. McNeill Jr. Distinguished Professor and studies the role of antiretroviral therapy in preventing the transmission of HIV along with the optimal dosing and drug combinations for treating HIV infection. She works to better understand and predict the distribution of drugs throughout the body, the interactions between drugs, and the roles that sex and ethnicity play in the way drugs are processed by the body.
She is the codirector of the pharmacology core of the $32-million UNC-led Collaboratory of AIDS Researchers for Eradication established in 2011. Kashuba will also play a major role in the recently announced partnership between the University of North Carolina at Chapel Hill and GlaxoSmithKline to develop a cure for HIV/AIDS.
Kashuba joined the UNC-Chapel Hill faculty in 1997. She is director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core and has served as the vice chair of research in DPET since 2011. She is a diplomat of the American Board of Clinical Pharmacology. Kashuba is the author of more than 190 peer-reviewed publications and has received more than $20 million in research funding.
After earning a bachelor’s degree in pharmacy from the University of Toronto, Kashuba completed a general practice residency at Women’s College Hospital. She practiced as an oncology pharmacist and as a critical-care pharmacist at Mount Sinai Hospital in Toronto and then attended the State University of New York at Buffalo to earn her doctor of pharmacy. Kashuba completed postdoctoral clinical pharmacology training at the Clinical Pharmacology Research Center at Bassett Healthcare in Cooperstown, New York.